IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — GNS

Balance Sheet

(in millions USD)
MetricFY 2025FY 2024FY 2023FY 2022FY 2021
Cash & Equivalents2.421.610.615.721.78
Inventory0.680.470.761.000.09
Total Current Assets23.8742.429.6324.256.50
Goodwill44.798.3411.4331.691.32
Total Non-current Assets*113.0758.6433.5867.0111.10
Total Assets136.94101.0643.2191.2617.60
Total Current Liabilities27.6211.6117.2523.387.14
Total Non-current Liabilities*12.7010.046.2553.932.47
Total Liabilities40.3221.6423.5077.309.61
Retained Earnings(137.96)(84.01)(59.13)(68.54)(13.49)
Total Stockholder Equity96.6279.4119.7113.953.64

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricFY 2025FY 2024FY 2023FY 2022FY 2021
Total Revenue8.397.9123.0618.1912.78
Cost of Revenue*5.525.3311.139.5510.02
Gross Profit2.862.5811.948.642.76
Research & Development0.620.810.880.850.46
Selling, General & Admin27.7522.4429.9021.077.21
Total Operating Expenses28.9932.6948.0050.226.93
Operating Income(26.13)(30.11)(36.07)(41.58)(4.17)
Interest Expense3.391.153.691.31--
Pretax Income(55.34)(27.19)(6.79)(56.32)(4.62)
Tax Provision0.65(2.25)(1.08)(1.06)(0.13)
Net Income(55.46)(24.94)(5.71)(55.25)(4.49)
Basic EPS(0.55)(1.03)(0.10)(2.44)(0.28)
Diluted EPS(0.55)(1.03)(0.10)--(0.28)

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricFY 2025FY 2024FY 2023FY 2022FY 2021
Operating Cash Flow(10.65)(46.35)(12.41)(8.24)(3.08)
Investing Cash Flow(2.21)(8.09)(2.84)(10.09)(0.88)
Financing Cash Flow13.9455.369.8521.943.10